Literature DB >> 10373185

Importance of health economics must be recognised when trials are designed.

A Haycox, A Bagust, T Walley.   

Abstract

Mesh：

Year:  1999        PMID： 10373185      PMCID： PMC1116035          DOI： 10.1136/bmj.318.7199.1696a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Analysis and interpretation of cost data in randomised controlled trials: review of published studies.

Authors:  J A Barber; S G Thompson
Journal:  BMJ       Date:  1998-10-31

2.  Generalisation from phase III clinical trials: survival, quality of life, and health economics.

Authors:  P M Fayers; D J Hand
Journal:  Lancet       Date:  1997-10-04       Impact factor: 79.321

Review 3.  Pharmacoeconomics: integrating economic evaluation into clinical trials.

Authors:  A Haycox; M Drummond; T Walley
Journal:  Br J Clin Pharmacol       Date:  1997-06       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.